US 8304511
Maleamic acid polymer derivatives and their bioconjugates
granted A61KA61K47/60A61P
Quick answer
US patent 8304511 (Maleamic acid polymer derivatives and their bioconjugates) held by Nektar Therapeutics expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/60, A61P, A61P11/00, A61P25/00